BSEResult6d ago · 13 Aug 2026, 11:23 pm

Financial Results for Quarter ended June 30, 2026

Krsnaa Diagnostics Ltd · 543328

✦ AI SummaryResults

Krsnaa Diagnostics Ltd has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with revenue from operations at INR 2,355.32 million, a 22.4% increase from the same period last year. The company has also declared a final dividend of INR 2.00 per share for the financial year 2024-25. Additionally, the board has approved the issuance of 16,21,000 share warrants to Mr. Rajendra Mutha and Krsna Diagnostics (Mumbai) Private Limited at a future determined price, which will be higher of the floor price as on the relevant date or INR 565.

Analysis Scores

Earnings Impact6/10
Growth Catalyst4/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Krsnaa Diagnostics Ltd - 543328 - Results - Financial Results For Quarter Ended June 30, 2026

Attachments (1)

📄

912aaf9d-a0f4-44c6-886a-ae150c033119.pdf

pdf

Download →
View document text
Date: August 13, 2026 Ref. No.: KDL/SE/027/2026-27 To, To, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Exchange Plaza, Plot No. C-1, Block G, 25th Floor, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (East) Dalal Street, Mumbai- 400001 Mumbai – 400051 Scrip Code: 543328 NSE Symbol: KRSNAA Subject: Outcome of Board Meeting held on August 13, 2026. In compliance with Regulation 30 and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, read with Schedule III of aforesaid regulation and SEBI Circular No. SEBI HO/49/14/14(7) 2025-CFD-POD2/I/3762/2026 dated January 30, 2026 we would like to inform you that the Board of Directors of the Company at its meeting held today i.e. August 13, 2026, has discussed and approved the following items: a. Unaudited (Standalone and Consolidated) Financial Results for the quarter ended June 30, 2026 along with the Limited Review Reports as issued by the statutory auditors of the Company, enclosed as Annexure –A; b. Director’s report along with all the Annexures forming part of the Annual report of the company for the financial year 2025-26; c. Notice of the 16th AGM of the Company which would be held on Monday, September 28, 2026 at 11:00 Hrs. (IST) through in Physical Mode, inter-alia, to transact the business as set out in the said Notice. Sr. No. Particulars Remarks 1 Date and Time of AGM Monday, September 28, 2026 at 11:00 Hrs. (IST) 2 Mode of Meeting as per Regulatory Physical Mode Requirement 3 Record date for Payment of Final Friday, September 18, 2026 Dividend 4 Book Closure Date From: Saturday, September 19, 2026 To: Monday, September 28, 2026 (Both Days inclusive) 5 Dividend Declared by Board May 25, 2026 6 Final Dividend recommended for F.Y. INR 2.00/- (Rupees Two only) 2024-25 7 Contact details of the Company Mr. Sujoy Sudipta Bose Company Secretary and Compliance Officer Email ID: investors@krsnaa.in Contact No.: (+91) 20 27402400 d. The issuance of 16,21,000 share warrants to Mr. Rajendra Mutha and Krsna Diagnostics (Mumbai) Private Limited (Promoter and Promoter Group) up at an issue price determined in future, which would be higher of the following:  The floor price as on the relevant date in the future as determined in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 or;  Rs. 565/-. The Board Meeting commenced at 13:30 Hrs. (IST) and concluded at 21:00 Hrs. (IST) Thanking you, Yours sincerely, For Krsnaa Diagnostics Limited Sujoy Sudipta Bose Company Secretary and Compliance Officer Encl: As above Krsnaa Diagnostics Limited CIN:L74900PN2010PLC138068 Statement of Unaudited Consolidated Financial Results for the quarter ended June 30, 2026 (INR Million, except earnings per share) June 30, 2026 , (Audited) Unaudited) Unaudited) Audited’ Joietestir (Refer Note 5) t ! t } Income Revenue from operations 2,355.32 1,926.04 1,929.78 7,727.74 Other income 72.40 314,99 39.50 433.90 |___|Totalincome 2,427.72| 2,241.03] 1,969.28 8,161.64 Expenses. Cost of material consumed 501.86 443.74 474.26 1,790.45 Employee benefits expense 360.59 333.48 355.63 1,404.83 Finance costs 148.34) 120.84 63.00 343,64 Depreciation and amortization expense 279.55 225,87 216,32 904.61 Fees to hospitals and others 405.85 143.04 153.65 617.08 Other expenses 507.22 457.00 432.28 1,796.67 |__|Totalexpenses | 2,203.41 1,723.97 1,695.14 6,857.28 | on before share of profit in associate and tax (1) - 224,311 517.06 274,14 1,304.36 |__4| hare of profit/(loss) in associate SS ee a TT |__5|Profit before tax (3) + (4) | —s224.36| 517,01 274.22 1,303.67 Tax expenses Income Tax charge 57.84 84.58 58.31 245.29 Income Tax charge relating to earlier year - : (1.26) Deferred tax charge 1.01 15.25) 10.71 45,33 |__|Totaltaxexpenses |S 99.83 69.02 289.36 Profit for the period/year (5) - (6) | 65.51] ata] 205.20] 1,014.3: Other comprehensive income Items that will not be reclassified subsequently to profit and loss Re-measurement gains / (losses) on defined benefit plans 1.20 1,20 1.88 2.96 Income tax effect (0.30) (0.30) (0.47) (0.92) Total other comprehensive income/(loss) for the 141 period/year | | in comprehensive income for the period/year (7) +| 166.41 418,08 | 206.6 1,016.35 Profit for the period/year Attributable to: Equity Holders of the Holding Company 165.51) 417.18 205.20 1,014.31 Non Controlling Interests - : : = PT 165.51] a17.ta| 208.20| 1,014.31 Total other comprehensive income /{loss) for the period/year attributable to: Equity Holders of the Holding Company 1.41 2.04 Non Controlling Interests a |) 2) | eX) Total comprehensive income for the period /year attributable to: Equity Holders of the Holding Company 166.41 418.08 206.61 1,016.35 Non Controlling Interests . 9 E: -] | 166.41 418.08] 206.61 1,016.35 Paid-up equity share capital (Face Value of INR 5/- 162.19 162.19 462.19 162.19 each) Other equity 9,641.69) Earnings per equity share (Not annualised for period): Basic (INR) 5.10} 12,86 6.35 31.30 Diluted (INR) 5.04 12.70 6.25 30.88 O12 Nos For and on behalf of Board of Directors / oy Se KrsnagDiagnpstics Limited 5 th 2 5) Y) \ Sf Rajendra Mutha Place: Pune “NS 4 As)w i Chairman & Whole-time Director Date: August 13, 2026 i DIN: 01066737 Krsnaa Diagnostics Limited CIN:L74900PN2010PLC138068 Notes to Unaudited Consolidated Financial Results: 1.These unaudited consolidated financial results (‘consolidated financial results’) of Krsnaa Diagnostics Limited (‘the Holding Company’) have been reviewed by the Audit Committee and approved by the Board of Directors on August 13, 2026. 2.The above consolidated financial results have been prepared in accordance with the Indian Accounting Standards notified under Section 133 of the Companies Act 2013, as amended, read with relevant rules thereunder and in terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) 2015, as amended. 3. The Group's operations predominantly relate to providing diagnostic services in radiology and pathology services. The Chief Operating Decision Maker (CODM) reviews the operations of the Group as one operating segment. Accordingly, the Group has single reportable segment and it derives entire revenue from the external customers in India and have entire assets located in India. The group has two major external customers which accounts for 10 per cent or more of groups revenues, 4. Pursuant to search and seizure proceedings conducted under the provisions of section 132(1) and section 133A of the Income Tax Act, 1961 ("the search operations"), the Holding Company received assessment order dated March 31, 2024 for Assessment Year ("AY") AY 22-23. Further, Orders for AY 23-24, AY 21- 22, AY 20-21 and AY 17-18 were received during the year ended March 31, 2025 and assessment orders for AY 2018-19 and AY 2019-20 were received on March 19, 2026 under the Income Tax Act, 1961 ("the Orders”). In the aforesaid Orders, the Income Tax authorities have made additions on account of undisclosed income and disallowance of certain deductions claimed by the Holding Company in the respective income tax returns filed for the relevant AY. Consequentially, it has resulted in a demand order of INR 626.90 million, The Holding Company has filed appeals against the aforesaid assessment Orders before the Joint Commissioner (Appeals)/Commissioner of Income- Tax (Appeals). Against the order for AY 2022-23,the Holding Company has deposited the tax under protest amounting to INR 39.27 million. Further, for the remaining AY's the Holding Company has requested to the Assistant Commissioner of Income Tax to adjust the income tax refunds for AY 2024-25 to the extent of INR 63.50 million against the amounts to be deposited under protest. These appeal applications have been acknowledged by the Commissioner of Income-Tax (Appeals). The Holding Company has provided the requisite disclosure to the stock exchange with resp [Showing first 8,000 characters — download PDF for full document]